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Abstract
Background: Malaria remains a major cause of mortality among under five children in Nigeria.
Most of the early treatments for fever and malaria occur through self-medication with antimalarial
drugs bought from medicine sellers. These have led to increasing calls for interventions to improve
treatment obtained in these outlets. However, information about the current practices of these
medicine sellers is needed before such interventions. This study aims to determine the medicine
sellers' perspectives on malaria and the determinants that underlie their dispensing patterns of
antimalarial drugs.
Methods: The study was conducted in Ugwugo-Nike, a rural community in south-east Nigeria. It
involved in-depth interviews with 13 patent medicine sellers.
Results: A majority of the medicine sellers were not trained health professionals and malaria is
recognized as a major health problem by them. There is poor knowledge and poor dispensing
behaviour in relation to childhood malaria episodes. Although referral of severe malaria is common,
there are those who will not refer. Verbal advice is rarely given to the care-givers.
Conclusion:  More action research and interventions to improve prescription and referral
practices and giving verbal advice to care-givers is recommended. Ways to integrate the drug
sellers in the health system are also recommended.
Background
Malaria is a major public health problem in Nigeria, being
one of the five leading causes of out-patient visits and
mortality, especially in children under five years of age
[1]. Prompt access to early diagnosis and effective antima-
larial treatment are major strategies for reducing morbid-
ity and mortality from malaria [2,3].
However, most of the early treatments for fever in most
developing countries occur through self-medication with
antimalarial drugs bought from patent medicine sellers
(PMS) [4-6]. In Nigeria, PMS are usually the first choice in
health care and a recognized primary source of orthodox
drugs for both rural ad urban populations, especially the
poor [7,8]. In addition to selling drugs, they are also a
major source of advice about illness and drug therapy [9].
The patent medicine seller can be defined as a person
without formal pharmacy training, who sells orthodox
pharmaceutical products on a retail basis for profit [10].
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Patent medicine stores are owned by the holders of patent
and proprietary medicine vendors licenses. Ordinarily the
patent medicines should be sold in their original packs.
Over-the- counter (OTC) drugs are the only drugs author-
ized to be sold by the vendors, but they generally sell all
types of drugs as determined by their financial capability
[11]: these range from paracetamol and chloroquine in
large tins to antibiotic, psychotropic drugs, narcotics, tox-
oids, and antihypertensives, that are outside the scope of
their license [12,13]. In addition, the PMS obtain their
drug supplies through both formal and informal channels
including large retail and wholesale pharmacies in major
cities, direct from pharmaceutical companies, and
through visiting company representatives [13]. There are
reports that these drugs may be ineffective, counterfeit or
expired [11].
The Pharmacy Law in Nigeria specifies that PMS should
sell only pre-packaged patent medicines. These laws show
that the government has positively responded by legisla-
tion to forestall a chaotic drug distribution and consump-
tion situation in Nigeria. But evidence suggests that drug
laws were adequate, falling short only in their implemen-
tation [11].
The PMS have a wide distribution, especially in low
income countries, and data on their actual number are dif-
ficult to obtain. However, studies show that they are the
major drug retailers both in terms of value of drugs sold
and number of outlets [14-16].
The reasons for preferring drug shops include geographi-
cal accessibility, shorter waiting times, more reliable drug
stocks, longer opening hours, greater confidentiality,
more personable social interaction, ease of seeking advice,
lower cost and flexible pricing policies and no separate fee
charged for advice [17,18]. However, one of the problems
associated with home management and self medication
with drugs from these sellers is that in most cases, neither
the drug seller nor the consumer is aware of the correct
dosage and duration of treatment [19]. Antimalarial drugs
rank high among the drugs administered by these sellers
in Nigeria [8]. However, effective management of malaria
is not guaranteed: for example, such sellers have been
found to consider analgesics containing aspirin as antima-
larial drugs [20] and the appropriateness of dispensing in
these drug outlets has been found to be suboptimal [21].
These practices may contribute to the spread of chloro-
quine-resistant  Plasmodium falciparium in Nigeria [22].
Also, the risks for poor quality treatment may be high, in
view of the fact that uncomplicated malaria can proceed
rapidly to severe disease and death, especially among
young children who have yet to develop immunity [23].
These have led to increasing calls for interventions to
improve treatment obtained in these outlets. However,
before instituting such interventions, information about
the current practices of PMS is needed as well as the deter-
minants that underlie the dispensing pattern of antimalar-
ial drugs in these outlets in Nigeria. While patent
medicine shops are acknowledged as a major course of
health care products, little has been reported on what
actually happens in the shops [10], especially from the
shop owner's perspective.
This study aims to determine the patent medicine sellers'
perspectives on malaria and their referral practices in a
rural Nigerian community. The result, which is part of a
larger study designed to ascertain healthcare providers
and caretakers' knowledge of malaria symptoms, causes,
treatment and referral practices, will help in designing
appropriate intervention measures that will help in
improving the dispensing behaviour of patent medicine
sellers.
Methods
Study area
The study was conducted in Ugwogo-Nike, one of the four
autonomous communities in Nike, Enugu state, Nigeria.
It has a projected population of 13,952 in 2002 and is
made up of 10 villages. It has a primary and secondary
school, a primary health centre and a comprehensive
health centre ('Cottage hospital'), both of which are situ-
ated in the same place, but one is managed by local gov-
ernment and the other by state government. Ugwogo-
Nike is about 20 kilometres from the state capital, Enugu.
This is predominantly a farming community.
Malaria is holoendemic, with a high malaria transmission
rate year round and an average malaria incidence rate of
20% [24]. The main malaria vector in Ugwogo is Anopheles
gambiae and P. falciparum is responsible for more than
90% of all malaria infections [24].
A total of 13 patent medicine sellers are registered with the
local association. Every four days a large market (in "Orie"
market square) attracts many customers from the capital
city and neighbouring villages. Market days offer a good
opportunity to communicate with community members.
Out of the 13 patent medicine sellers, two are located
around the market square and 11 are spread out in the 10
villages. Other sources of treatment for this community
include 34 traditional healers, the cottage hospital and
health centre, and several private and public health care
facilities, located in the capital city.
Study design
The study was a descriptive cross-sectional study.
Ugwogo-Nike was selected by simple random sampling
from a sample frame of the four autonomous communi-Malaria Journal 2006, 5:97 http://www.malariajournal.com/content/5/1/97
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ties in Nike. A census of all medicine sellers was taken by
two members of the community with the assistance of the
chairman of the local PMS association and a total of 13
were identified. The researchers worked through the chair-
man of the association to gain legitimacy and support,
since PMS are suspicious of outsiders who might be gov-
ernment agents, sent to check them out. Thus, the chair-
man introduced the researchers to the member PMS and
explained the purpose and nature of the study.
Data collection methods
In-depth interviews (IDI) were conducted with the PMS
using IDI guide to explore their knowledge, beliefs, and
stated treatment practices for mild and severe malaria, as
well as the referral practices for severe malaria. The inter-
view was conducted in the morning hours on non-market
days (when the patient flow to the drug sellers' stores was
minimal) by two community health nurses from the
Health Visiting Unit of the Department of Community
Medicine, who had previously been trained in qualitative
method techniques. Each interview lasted between 60 and
75 minutes. The interview was tape-recorded and notes
taken.
Data analysis
The transcriptions was organized under thematic head-
ings and later developed into an ethnographic summary
with illustrative quotes. The trajectories of their responses
to the questions were captured with a trajectory tree, and
then the different ranges of opinions, perception and
stated practices were noted.
Ethical considerations
Ethical approval was sought and obtained from the Ethi-
cal Committee of the University of Nigeria Teaching Hos-
pital, Enugu (UNTH). The research objectives and
methods were explained to individual respondents and
verbal informed consent to tape-recording the interviews
was obtained from the study participants before the inter-
view commenced. Confidentiality of all information
obtained from participants was maintained by not allow-
ing information to be accessible to non-members of the
research team.
Results
All 13 PMS were interviewed. They comprised of eight
male and five female practitioners. The age range was
from 26 to 42 years. While 10 of them had attained a min-
imum of primary education, three did not attend any
form of formal education. Apart from one nurse who had
attended a school of nursing, the highest educational
attainment of the sellers was a secondary school certificate
and only two had reached this level. All belong to an asso-
ciation of drug sellers, which offers them the opportunity
to fraternize together and helps in protecting the members
from undue harassment from government agents and
community members, as well as maintaining discipline
within the association. However, the association does not
provide any extra training materials and prescription
guidelines to the members. None had any formal health
training, except for the nurse who is also a registered
member of the Nigerian Nursing and Midwifery council.
A male drug seller pointed that 'you don't need to go to a sec-
ondary school or university to know how to sell these drugs. All
you need is to train under an experienced patent medicine
owner for about three years as an apprentice'.
Common illnesses affecting children under five years of age
Twelve of the drug sellers believe that, of all the illnesses,
malaria is most commonly associated with fever and all
affirmed that malaria is the most important of diseases
and the one that kills more often. The seller that differed
in this opinion was one of the two that had no formal
education and, as she put it, "as far as I am concerned ordi-
nary malaria does not kill children more than diarrhoea, it is
diarrhoea that kills the children faster than any other disease in
this community".
Causes and mode of transmission of malaria
On the causes of malaria, a few things were predominat-
ing in the drug sellers' responses. Some of the PMS have
more than one perception about the cause of malaria.
Thus, while ten of them felt that mosquitoes were the
main cause of malaria, six and four felt that it was due to
the sun and drinking bad water, respectively. Less than
four sellers also attributed malaria to bad food, cold and
body contact. When asked to state how the sun causes
malaria, one of them said "the sun can cause malaria when
it shines directly on the child". A majority of them believe
that mosquito bites transmit malaria, but how it does that
was not clear to them. As one of them explained "if a mos-
quito bites somebody who has malaria, it transmits his blood to
another person when it bites him and he will start to develop
Iba" (Iba meaning malaria in the local language).
Symptoms and signs of malaria
When asked to discuss the symptoms and signs of
malaria, they correctly identified them to be fever, head-
ache, weakness and restlessness for mild malaria. Accord-
ing to a female respondent, 'as a mother, I know that once a
child has fever and is restless and refuses food, then the child
has malaria'. Others include discoloration of urine and
skin, cold, vomiting, loss of appetite, stomach upset,
dreaming and excessive sweating. It was noted from the
responses of most of the drug sellers that one of the signs
indicating that the patient is getting worse is continuous
fever and as stated by most of them 'if the child continues to
have fever while treatment has gone far then you know the
problem is getting worse'. Some of the drug sellers, however,
noted that 'if the child starts jerking (convulsing), it is an indi-Malaria Journal 2006, 5:97 http://www.malariajournal.com/content/5/1/97
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cation that the condition is getting worse'. One of the
respondents who had no formal education also noted that
in some cases, the mothers describe the symptoms to her
and this helps her to classify the malaria. As she puts it 'if
the mother says the child has fever that comes with yellow eyes,
then I know that the child has serious malaria, but if she says
the fever came with only headache and joint pains, I know it is
ordinary malaria". This respondent, who is a nurse, seemed
to be more knowledgeable about symptoms and signs of
both mild and severe malaria than any other respondent.
Treatment practices
When the respondents were asked to say how they make
treatment decisions, eight respondents said the customers
simply asked for specific medicines, which they provided.
According to one male seller, 'when patients come to me,
they just say I need medicine for malaria and I give them the
antimalarial available in my store'. Again the quantity and
doses of antimalarial drugs sold to clients depends on the
amount of money available to the client and these drugs
are wrapped in a piece of paper by some of the PMS dur-
ing dispensing while some claimed to package the drugs
in small unlabelled envelopes. A respondent captured it
thus:  'at times the patients specify the medicine and the
amount of money they have and I sell the medicine to them
which corresponds to the amount they have'. But two of the
respondents including the nurse claimed that when
patients present an illness complaint, they take history
and examine them before recommending any drugs to
them. In some cases also, the patients come with a pre-
scription sheet from a doctor and they issue them medi-
cine if available in their store. According to the nurse, 'it is
easier for me if they come with a prescription' while one of the
male sellers with primary education said 'if they come with
a prescription, I ignore it since I can't read doctors' writing. I
will rather ask the patient what is wrong with him/her and
treat'.
On the drugs which they sell to patients, all the sellers
indicated a higher use of analgesics/antipyretics (paraceta-
mol/analgin) as an addition to antimalarial drugs because
according to most of them 'it reduces the fever fast and helps
the antimalarila to be very effective'. Five of the sellers also
felt that the analgesics/antipyretics can cure malaria on its
own. As one male seller puts it 'if a customer comes with
fever and especially headache, I just give them novalgin injec-
tion and the fever and headache disappears'. Eleven of the
sellers will use chloroquine as their first line drug admin-
istered as injection. When asked the reasons for the use of
chloroquine, most of the sellers said chloroquine is the
cheapest antimalarial and the patients can afford it. Also
eleven of the sellers felt it is still very effective in treating
malaria. Only one out of the thirteen interviewed believed
halofantrine is more effective and uses it if patients can
afford it. According to him, 'this chloroquine don't work any
more, so when my patients come, I tell them about Halfan
(Halofantrine) and if they can afford it, I sell it to them oth-
erwise I give them chloroquine or Fansidar' (sulfadoxine/
pyremethamine, SP). All the sellers had some knowledge
of SP preparations and one of them prefers it because
some patients believe 'it is more effective than chloroquine
and does not cause scratching'.
For what is assumed to be mild malaria, ten of the sellers
will dispense chloroquine tablets and syrup to patients
and ask mothers to give it to the child three times in a day,
for a period of 3–5 days and sometimes extending to more
than five days. But when chloroquine injection is used,
the medicine seller administers it him/herself once a day
in combination with vitamin B complex injection.
According to some of them, 'vitamin B complex helps to
build up the blood which malaria infection have consumed'.
However three of the sellers felt differently. According to
one of them, 'I give vitamin B complex so as to increase my
bill'. When asked why they administer injections, they
claimed it was more effective than the tablets and the
syrup and in some cases, it is due to the demand of the
patients. This was captured by one of the male sellers thus
'you know injections work faster and at times the patients
demand that we give it to them'. Another respondent stated
that 'to make our charges higher, we have to administer injec-
tions as this is the only way they can respect you'. They also
claimed that, at times, they dispense these drugs according
to the amount of money the customer came with.
Nine of the sellers will recommend the same dosage of
chloroquine to all children less than five years of age.
Also, some will recommend a single dose of chloroquine
for children less than five years old, instead of the required
three-day treatment. When reminded that all these might
be an over-dose or under-dose for the children, one of
them insisted that 'I have been doing this for a long time and
they have been recovering without any problem'. The drug
seller who prefers "maloxine" a brand of SP would not
change to another antimalarial even if symptoms persists
because according to him 'the illness is no more malaria'. For
severe malaria, they indicated that they make use of chlo-
roquine and analgesics (paracetamol) as major drugs
while administering vitamin B complex injection if there
is need. Other drugs they make use of though less fre-
quently are analgin injection (antipyretic), maloxine (a
brand of SP), maloquine (mefloquine), halfan (halofan-
trine) and multivitamin tablets. Very few indicate their
use of blood tonics and drips (intravenous infusion).
Three of the PMS interviewed claimed that they rely on the
instruction provided by the manufacturers in selling and
dispensing the drugs.
Although all the respondents have heard of artemisinin
derivatives, none stored them because as they claimed 'weMalaria Journal 2006, 5:97 http://www.malariajournal.com/content/5/1/97
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cannot stock because of the high cost. If you do, no villager will
buy it from you because they are very poor'. However, the
respondent who stored halofantrine said he cannot afford
to store two expensive antimalarial drugs at same time,
but claimed that he has on two occasions, bought it for a
client who requested it. And on those occasions, the client
was said to have got better faster. As he put it 'there is one
woman who is always requesting for coartem (ACT) and each
time, she comes back to say the drug is wonderful but expen-
sive'. The respondent said he would be willing to store the
drug if there is a demand for it. Apart from prescribing and
dispensing drugs, most of them indicated that they will
also tepid sponge the child to bring down the tempera-
ture. When questioned on why they have to prescribe and
what guides their treatment decision, the response from
most of the drug sellers was that they have the experience.
For the convulsing child all claimed they will refer to a
health facility. Two of them will tepid sponge and give
antipyretics before referral, while one drug seller will give
an anti-emetic promethazine or administer an anticonvul-
sant "phenobarbitone" before referral.
Only five of the sellers will communicate to the caregiver
the dosage of the medicines and none of the sellers will
communicate the precautions and side effects of the med-
icines purchased by the patient.
Referral practices
On referral practices, most of the sellers hardly refer
patients to the health centre or the cottage hospital in the
community because 'the workers are hardly ever there and
there is no doctor in the places'. However, three of the drug
sellers claimed they would refer patients to the cottage
hospital for the treatment of mild malaria, but if the child
develops convulsion, nine of them will refer to a doctor in
the city. The nurse claimed that she refers all cases not
responding to antimalarial drugs to a doctor in the capital
city. As she put it 'any malaria I cannot treat here cannot be
treated at the health centre. So I have to refer them to a doctor
in the urban'. For those who will refer, they were asked to
state the mode of referral. Only the nurse said she will give
the caregiver a referral note to the facility. The rest will
only ask the caregiver to go elsewhere verbally. A few,
however, indicated they will not refer, but rather treat the
cases by making use of paracetamol or novalgin, (analge-
sics/antipyretic), paraldehyde (anticonvulsant) and pro-
methazin (anti-emetic) injections. As put by one of them
, 'I am very good at treating malaria, so I don't need to refer to
anybody. When you refer, the mothers will think you don't
know anything and will not come another day'.
Discussion
This study documents the knowledge and stated practices
of medicine sellers for the treatment of childhood malaria
in a small rural community. The results show that only
one drug seller had a health training background. This is
a very low figure and contrasts with studies done in
Uganda, where a majority of them had one form of health
training or another [25]. The PMS's educational level is
usually not specified in laws governing licensing of such
practice although by convention, as is the case in Nigeria,
the minimum educational attainment has been primary
schooling [26]. These sellers have been known to enter the
business from a variety of backgrounds unconnected with
having adequate knowledge of illness perception and
management, making effective malaria control impracti-
cable [27]. Although having a health education back-
ground is not required for registration of their premises,
having no form of health training is likely to contribute to
inappropriate dispensing of antimalarial drugs, especially
where some of the respondents do not have even a pri-
mary education.
Although the respondents were generally well informed
about symptoms and causes of malaria, there were some
misconceptions about the causes of malaria, incriminat-
ing the hot sun and drinking bad water. This perception is
likely to pose problem when taking decisions on what
drugs to give. It has been noted that knowledge of the
causes of disease and their symptoms and signs is impor-
tant guide in determining the choice of drug treatment
[25]. The fact that the nurse was more knowledgeable
than the rest underscores the need for the sellers to have
either formal or informal medical knowledge.
In this study, chloroquine is still commonly used and
inappropriately too by the drug sellers in conjunction
with antipyretics/analgesics (paracetamol and analgin).
This undermines therapeutic efficacy and may promote
the emergence and further spread of drug-resistance. In
Nigeria there has been a change in the national antimalar-
ial drug policy to artemisinin-based combination therapy
(ACT) as a first line drug for the treatment of uncompli-
cated malaria because of chloroquine resistance. In real-
ity, access to ACT is still very poor and most cases of
malaria are still treated with chloroquine by the PMS.
Furthermore, chloroquine injections were administered
commonly, a finding consistent with earlier studies in
Nigeria [28,29]. The use of chloroquine injections may be
an indication that sellers are primarily motivated by their
need to make profits, and not by any wish to provide a
public health good. It has been noted that prescribing pat-
terns are more likely to follow patient demands and
expectations and profit motive rather than professional
principles. There is concern about the frequent adminis-
tration of injections by individuals with no health back-
ground especially in light of the high risk of transmitting
HIV and other blood-borne infections [30]. Thus training
alone is unlikely to deal with the issue. Hence the need forMalaria Journal 2006, 5:97 http://www.malariajournal.com/content/5/1/97
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appropriate monitoring and media campaign by govern-
ment. The current effort in Nigeria by the National Agency
for Food and Drug Administration and Control (NAF-
DAC) on dangers of unnecessary injections through mass
media campaign is a step in the right direction.
Although a good number of the vendors had adequate
knowledge of signs and symptoms of malaria, the results
show that their knowledge of correct antimalarial dosage
is low for both mild and severe childhood malaria leading
to the administration of both over- and under-dosage of
antimalarial drugs. This same phenomenon was noted
elsewhere [31]. The ineffectiveness of these practices rep-
resents a major problem, since many malaria deaths occur
within the first 48 h of illness [23]. The great danger with
under dosage is also the development of chloroquine-
resistant strains of P. falciparum which has reduced the
efficacy of chloroquine in Nigeria [32].
Analgesics/antipyretics are always prescribed in this study
with chloroquine. Some of the medicine sellers appear to
confuse analgesics/antipyretics with antimalarials. This is
a common phenomenon and had previously been noted
in Nigeria [20].
Halofantrine is still being used by some of the drug sellers.
The cardio-toxicity effect of halofantrine has been docu-
mented [33] and this drug has been banned by some
countries because of this. However, it is interesting to note
that the sellers are knowledgeable about ACT. It will be
worthwhile to explore this in the wake of changing anti-
malarial first line drug policy in Nigeria to see the possi-
bility of making ACT available to consumers through the
PMS in the spirit of public-private partnership.
Although referral of severe malaria cases was common, lit-
tle or no verbal advice is given to mothers and no formal
arrangement is made to facilitate the referral. This could
be improved through training of both mothers and the
PMS on recognition of conditions warranting referral and
establishing a network between the PMS and the formal
health sector as well as the local transport union to ensure
easy accessibility.
Limitation of the study
The study involved only 13 drug vendors in a small area.
However, there has been a recent surge of international
interest in health-related small area studies and the World
Bank is encouraging the use of small area analysis [34].
The results of this study may reflect what is happening in
rural areas of Nigeria because it has all the features of a
typical Nigerian village. Furthermore, the results com-
pares with other studies in Nigeria [10,13] and will be use-
ful in guiding intervention studies targeted at rural
communities and the health sector and thus reduce the
effect of malaria.
Conclusion
This study brings up the issues regarding the poor knowl-
edge and poor dispensing behaviour of PMS in relation to
childhood malaria episodes. It has been shown that most
of the drug sellers were not trained health professionals
and malaria is recognized as a major health problem by
most of them. However, there are some misconceptions
on its causes and PMS are currently not very good at pro-
viding appropriate advice and adequate doses of antima-
larial to their clients. Training and periodic re-training of
drug sellers to enable them provide correct and full ther-
apy for uncomplicated malaria, appreciate the importance
of giving verbal advice to care-givers and recognize and
refer promptly all severe malaria cases is recommended.
The effectiveness of such trainings has been recorded in
different settings [23,35-37].
PMS knowledge about product dosages and precautions
could also be improved with the provision of better prod-
uct description by pharmacy companies and the pre-pack-
aging of antimalarials for young children. This has been
found to be effective in Nigeria [38].
There is need for sustainable monitoring systems. Moni-
toring and influencing the quality of private services is
now recognized as a key component of effective malaria
treatment [39]. The PMS union can be used to monitor
themselves when trained and this novel idea will be tested
during the intervention phase of this study. At present, the
PMS are registered and monitored by the state Ministry of
Health, Pharmacy division.
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